Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
TG Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
TG Therapeutics (TGTX) Announces $200M Proposed Public Offering of Common Stock
-
TG Therapeutics Announces Proposed Public Offering of Common Stock
-
TG Therapeutics to Present at Upcoming Investor Conferences
-
TG Therapeutics (TGTX) Prices 8.5M Share Upsized Common Offering at $18/Sh
-
TG Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
TG Therapeutics (TGTX) Announces Proposed 6M Share Public Offering of Common Stock
-
TG Therapeutics Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Starts TG Therapeutics (TGTX) at Overweight
-
Pre-Open Stock Movers 03/01: (PBYI) (GPS) (ZS) Higher; (IMGN) (NTNX) (TSLA) Lower (more...)
-
TG Therapeutics (TGTX) Announces Approximately $85 million in Equity and Debt Financings
-
TG Therapeutics Announces Approximately $85 million in Equity and Debt Financings
-
After-Hours Movers 02/28: (GPS) (PBYI) (FNKO) Higher; (MRSN) (NTNX) (TSLA) (more...)
-
TG Therapeutics (TGTX) to Offer Common Stock
-
TG Therapeutics Announces Proposed Public Offering of Common Stock and Closing of $60.0 Million Venture Debt Financing
-
TG Therapeutics, Inc. to Present at Upcoming Investor Conferences
-
TG Therapeutics, Inc. to Present at Upcoming Investor Conferences
-
Notable Analyst Rating Changes 5/27: (CAL) (VSLR) (NUVA) Upgraded; (WDAY) (SIG) (AAPL) Downgraded
